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ABSTRACT.
Hormones (sex hormones, thyroxine, cortisol and parathyroid), 
cytokines (interleukins-1 and 2 and tumour necrosis factor), life style 
(exercise, smoking and reproductive history), nutrition (calcium, meat, 
vegetables, vitamin D, caffeine and alcohol) and diseases (diabetes 
mellitus, malabsorption and thyrotoxicosis) affect bone mass. The loss of 
calcium, phosphate and magnesium from bone makes it weaker which 
enhances the incidence of bone diseases such as osteoporosis and 
osteoarthritis and increases the risks of fractures causing pain, sufferings 
and even death particularly in older females. Treatment of these diseases 
and the 200,000 related fractures costs the National Health Service over 
£940 millions annually (National Osteoporosis Society, 1998/1999).
The multifactorial aetiology of osteoporosis and difficulties in 
deciding the most effective treatment to suit individual sufferer makes 
preventative measures more suitable in lowering the incidence of this 
disease and therefore reduces human sufferings, cost and mortality.
Boron, a ubiquitous element in soil, water, ground vegetables and 
fruits modulates sex hormones in animals. Its role in human is unclear 
and inconclusive. Boron prolonged the half-life of 17(3 oestradiol and 
delayed the loss of bone mass particularly in post-menopausal women 
with low magnesium (Neilsen, 1990) and increased absorption and 
retention of calcium, phosphate and magnesium during vitamin D 
deficiency (Hunt, 1994). Excessively high level of boron suppressed sex 
steroids and increased the loss of bone minerals (Benderdour et al, 1998). 
Cortisol reduced bone mass (Delany et al, 1995) but the effects of 
catecholamines on bone are largely undetermined.
This study aims to assess the relationship between boron, cortisol, 
catecholamines, serotonin and bone turnover in relation to age, gender,
life style, nutrition, reproductive history and health status in men and 
women of 3 age groups, mainly nurses and to make recommendations, if 
appropriate, to improve bone mass or reduce the rate of bone loss.
172 male and female volunteers were placed in respective groups 
aged 11-20, 20-40, over 40 years old and all the pregnant subjects in one 
group. Early morning urine was analysed for calcium and magnesium by 
flame spectrophotometry, phosphate, hydroxyproline and creatinine by 
spectrophotometry, boron by inductive coupled plasma 
spectrophotometry and cortisol, adrenaline, dopamine and serotonin by 
high performance liquid chromatography. Information about each 
subject's life style, nutrition and health was obtained using a 
questionnaire. Data were processed and analysed using excel and minitab 
packages and only significance level at P<0.05 or less was accepted 
using ANOVA, t-test and Pearson's correlation coefficient.
There were positive trends between urinary levels of boron and 
calcium and significant correlation (P<0.05) between boron and 
phosphate in all the male subjects particularly in M20-40, suggesting that 
these subjects would be more prone to bone loss. In addition, the levels of 
boron were significantly higher (PO.05) in post-menopausal compared to 
pre-menopausal subjects, in F<20 low alcohol drinkers compared to 
M<20, during stress in M20-40 compared to F20-40, in F>40 with the 
history of osteoporosis compared to those in M>40 as well as in F20-40 
heavy smokers compared to those in M20-40 and in subjects taking the 
contraceptive pill. Age, exercise, hysterectomy, HRT, vegetables 
consumption and vitamin supplements did not significantly influence 
urinary boron levels. Heavy alcohol consumption, greater stress, heavy 
smoking and family history of osteoporosis increase urinary boron levels 
and this might enhance bone damage, particularly in post-menopausal 
subjects.
Urinary cortisol, adrenaline and dopamine levels were raised 
(P<0.05) in F>40 and M>40 and correlated with an increased calcium 
excretion which suggest that the increased catecholamine levels in these 
subjects may promote calcium loss and compromise ageing bone. 
Regular intake of alcohol above 1500 ml of beer, 750 ml of wine and 150 
ml of spirits per week, heavy smoking of over 10 cigarettes or 3 ounces of 
tobacco per day, eating less than 3 vegetables, not taking weight bearing 
exercises at least 3 times per week and a lack of multivitamin 
supplements during puberty and middle age, increased bone turnover and 
may predispose bone to fractures. Male nurses were at a greater risk 
(PO.05) than the females from increased turnover of phosphate, 
magnesium, calcium and hydroxyproline as these also positively 
correlated with either boron, adrenaline or cortisol. The levels of urinary 
catecholamines were significantly (PO.05) higher in M20-40 compared 
to F20-40 who were stressed and suggested either male subjects had poor 
coping mechanism or that female subjects had a different response 
mechanism. The correlation between boron, cortisol, adrenaline and 
phosphate in the male subjects as a whole but particularly in M20-40, in 
whom adrenaline also correlated with hydroxyproline, suggest that these 
male subjects are at greater risks of bone damage and poor health.
Improved dietary intakes of calcium, vegetables and boron and a 
healthier life style of reduced alcohol and smoking with more weight- 
bearing exercises could significantly reduced bone loss and therefore 
prevent osteoporosis. In addition, male nurses should minimise stress 
levels not only to protect bone loss but for a better health.
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You say you are afraid of the a-rays
Put on sheets of paper to keep it away.
A p-rays needs much more care
Place sheets of metal here and there,
And as for the powerful y-rays
Pay careful heed to what I say: 
Unless you wish to spend weeks in bed
Take cover behind thick slabs of lead. 
Fast neutrons pass through everything
Wax slabs remove their nasty thing 
These slow them down; even a moron
Knows they can be absorbed by boron.
Remember, remember all that I have said
Because it's no use remembering when you are dead,
Harry Chummun. 
1999.
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OSTEOPOROSIS CAUSES BONE TO BECOME POROUS WmCH BREAKS VERY
EASILY. 1 IN 3/4 WOMEN AND 1 EV 12 MEN WILL DEVELOP OSTEOPOROSIS.
IT AFFECTS PEOPLE OF ALL AGES BUT PARTICULARLY AFTER THE AGE
OF 50, CAUSING FRACTURES, INCREASING MORBIDITY AND MORTALITY.
(NATIONAL OSTEOPOROTIC SOCIETY 1999).
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STRUCTURES AND FUNCTIONS OF BONE.
1.0.0. Introduction.
Bone, a specialised form of connective tissue, made durable by the 
deposition of minerals within its infrastructure, can be long, short, flat and 
irregular. It gives shape and form to the body, protects internal organs, stores 
minerals and provides the site for blood cell production. It is made up of 
cortical and trabecular bone tissues which are living tissues and undergo 
continuous growth, development and repair. These tissues originate from 
mesenchymal stem cells and eventually differentiate into osteoblasts, 
osteoclasts, osteocytes and osteogenic cells. In addition, bone is also made up of 
organic and inorganic substances. The organic component consists of the bone 
cells and collagenous and non-collagenous proteins. The inorganic substances 
are mainly calcium hydroxyapatites, made up principally of calcium and 
phosphate crystals with sodium and magnesium. The intercellular bone matrix 
is impregnated with inorganic calcium salts which provide tensile and 
compressible strength. Several cytokines, such as interleukins 1 and 2, 
hormones, such as cortisol, insulin, oestrogen and testosterone, life style such 
as alcohol consumption, exercise and dietary minerals, such as calcium and 
vitamins, influence bone cells activities and either promote growth or 
resorption of bone.
Long bone has a central diaphysis of dense and compact bone and the 
region at each end are the epiphysis, growth plates and metaphysis which 
become calcified following completion of pubertal growth. Growth in length 
occurs by the deposition of new bone tissue at the metaphysis which then has to 
undergo subsequent mineralisation. The diaphysis consists of compact bone and
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the periosteum, which is the outer surface layer of the diaphysis, consists of 
fibrous tissues and nerve endings and is richly supplied with blood vessels. Its 
innermost layer is secured to the underlying bone by tufts of collagen fibres 
which extend from the fibrous layer into the bone matrix. The endosteum layer 
separates the medullary cavity from the surrounding compact bone and contains 
osteoblasts as well as osteoclasts.
Bone is made up of two main types of tissues; trabecular and cortical. 
Trabecular bone found internal to cortical bone and at the end of long bones, 
comprises of trabeculae seperated by marrow spaces (Marieb, 1997). This bone 
has a high surface-to-volume ratio and provides the environment for calcium 
and phosphates metabolism. Cortical bone makes up the outer layer of long 
bones and vertebrae and has a low surface-to-volume ratio (Reid, 1997). About 
80% of the skeleton is cortical bone providing ridigity and density as well as 
weight bearing properties.
Bone contains collagen fibres arranged in parallel or concentric sheets or 
lamellar bone (Weinstein & Buckwater, 1994). Lamellar bone is found around 
blood vessels forming Haversian systems in long bone. Collagen fibres, found 
in woven bone, are formed when bone is laid down rapidly, as in foetal growth 
or during healing of fractures, and are interlaced and randomly dispersed with 
hydroxyapatite crystals in a disorganised fashion unlike in lamellar bone where 
they are deposited parallel to the collagen fibres (Odell & Heath III, 1993). 
Bone tissues are dynamic and continually being remodelled. In the foetus, bone 
develops from previously laid down cartilage, which is eventually resorbed and 
replaced with bone tissues through endochondrial ossification (Suta & Yasin, 
1998). However, bones of the calvaria, such as mandible and maxilla, 
developed from mesenchymal cells, and are formed through intra-mesenchymal 
ossification. In bone modelling, a process associated with growth and shaping of 
bone during childhood and adolescence, longitudinal growth of long bones 
depend on proliferation and differentiation of cartilage cells at the growth plates
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while growth in width and thickness is accompanied by formation of bone at the 
periosteal surface (Ng & Roma, 1997). In adults, after the closure of the 
epiphysises, growth in length ceases, but remodelling of bone, a life-long 
renewal activitiy continues through which old bone is removed by osteoclasts 
and replaced with new uncalcified bone tissues followed by mineralisation with 
hydroxyapatite crystals by osteoblasts (Eriksen et al, 1993). Parfitt, (1994) 
estimated that in humans, as much as 25% of trabecular bone and 3% of cortical 
bone is resorbed and replaced each year. This coupling of bone resorption and 
formation is influenced by hormones, local growth factors, cytokines and 
nutrients (Molgaard & Thompson, 1997).
1.1.0. Functions of bones.
Bone provides a supportive framework for soft tissues and protects 
delicate internal organs such as the bones of the skull, which form a bony cage 
for the brain tissues. Tendons are attached to the ends of long bone to facilitate 
movements, for example, bone of the legs during walking. The matrix of long 
bone stores minerals such as calcium, phosphate and magnesium and releases 
them into blood when their levels fall below normal ranges. Bone marrow 
produces most of the blood cells.
1.1.1. Bone matrix.
Bone matrix, produced by osteoblasts, consists of collagen and 
mucopolysaccharides. The mineralised organic matrix makes bone resistant to 
fractional and torsional forces. Intrinsic bone matrix disorders are rare and 
usually involves defective mineralisation for example hypophosphatasia, a rare 
autosomal recessive disorder in children and adults with associated rickets. 
Extrinsic factors which inhibit bone matrix mineralisation are even rarer for 
example, fibrogenesis imperfecta, in which serum alkaline phosphatase is 
increased with disorganised matrix and delayed bone mineralisation.
1.1.2. Bone collagen.
Collagen, a major component of connective tissues, is synthesised by 
osteoblasts and consists of a helix of three long alpha polypeptide chains. It has 
a triple helical structure made up of three collagen polypeptide sub-units, called 
a- chain, which are twisted together to form the helix. The innermost 
polypeptide consists of a repeating sequence of glycine residue (GLY-X-Y)n 
in which the X and Y positions can be any amino acid. About 100 of the X 
positions are occupied by proline and 100 Y by hydroxyproline. Proline and 
hydroxyproline residues impart considerable rigidity to the structure. Collagen 
fibres are further stabilised by the formation of covalent cross-links both within 
and between the triple helical units. These crosslinks are formed through the 
action of lysyl oxidase, a copper-dependant enzyme that oxidatively deaminates 
the s-amino group of lysine and hydroxylysine residues, yielding reactive 
aldehydes which stabilise the covalent cross-links to provide tensile strength 
to the fibres (Bonde et al, 1994). The deposition of calcium phosphate crystals 
during bone mineralisation, imparts further hardness and strength to the 
collagen.
Pyridinoline and deoxypyridinoline are non-reducible cross-links of 
collagen and while pyridinoline and hydroxyproline are also found in other 
tissues such as ligament and cartilage, deoxypyridinoline is relatively bone 
specific. The ratio of pyridinoline : deoxypyridinoline, in urine, is 3.5:1 (Eyre 
& Kobb, 1984). Total urinary pyridinoline and deoxypyridinoline can be 
measured by reverse phase HPLC but they do not always reflect changes in 
plasma pyridinoline or deoxypyridinoline as little is known of the renal 
handling or metabolism of these substances (Colwell et al, 1993).
Collagen is formed from protocollagen molecules synthesised and 
secreted by the osteoblasts which then undergo a number of post-translational 
modifications (Fig. 1.0) including the hydroxylation of proline and lysine to 
form hydroxyproline and hydroxylysine respectively. The terminal propeptides
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fMfif 
OGAL Procollagen Cell membrane
Procollagen
1 Procollagen peptidases
Tropocollagen *'
Fibre and cross-link formation
Cross-link maturation
Insoluble collagen
1.0. The biosynthesis of collagen.(St.John-Dixon & Woolf D.A. 1988V
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1.1.3. Bone cells.
(fig. 1.1) 
Osteoprogenitorcell Osteoblast Osteocyte
Fig.1.1. The four different bone cells (Marieb E. 1997).
1.1.3(a) Osteoblasts.
1.1.3(b) Osteoclasts.
1.1.3(c) Osteocytes.
1.1.3(d) Osteogenic cells.
1.1.4. Bone development
1.1.4(a) Intramembraneous ossification.
(fig. 1.2). 
1.1.4(b) Endochondral ossification.
(fig. 1.4.). 
KJ

1.1.5. Types of bone tissues.
1.1.5(a) Cortical bone.
fig.1.3). 
1.1.5(b). Trabecular bone.
Cortical (compact) bone
Subperiosteal
circumferential
lamellae
Periosteum
Endosteal 
surface
Capillaries 
in haversian 
canals
Periostea! 
vessels
Trabecular bone
Trabecular 
bone
Osteoid-
Active osteoblasts 
produce osteoid
Marrow spaces
contain
hematopoietic,
cells and fat 
Osteocyte
Cortical (compact) 
bone
Osteoclasts 
Trabeculai
Fift. 1.3a & 13b. Structures of cortical and trabecular bone tissues.
(Birdwood G, 1996V
(fig. 1.3a). 
1.1.6. Mineralisation of bone.
1.1.7. Types of bone growth.
1.1.7(a) Longitudinal bone growth.
(fig. 1.4). 
1.1.7(b) Appositional bone growth.
1.1.7(c) Bone modelling.

1.17(d) Bone remodelling.
(fig. 1.5). 
MARROW STROMA
Mononuclear ff (f^& ^ 
Phagocyte system ^ -^t^y Sinusoidal space
Monocyte
Endothelial 
ibroblast cell
Tissue 
Macrophage
Pleuripotential
'steoprogenitor cell
Resting Osteoblasts(lV)
ngteoblasts(lll)
Osteoclastic 
Resorption
Inactive 
Resorption
steoblastic 
delling
0)
RESTING SURFACE RESORPTIVE SURFACE FORMATION SURFACE
Fig.1.5. Remodelling of bone (Compston E. 1996^.
1.1.8. Factors affecting bone growth, composition and mass.
fig. 1.6). 
1.1.8(a) Genetic factors.
1.1.8(b) Age.
fig. 1.6).
JX^FEMALES 
Menopause
10 20 30 40
Genetic factors 
Calcium intake ^"  
Mechanical loading
i Structural changes
Fig. 1.6. The relationship between age and bone mass.
(Birdwood G. 19961
(The peak bone mass attained in early adulthood, is normally 
higher in men. Women, therefore, only need to lose about half as much 
bone as men to become osteoporotic. Factors influencing modelling and 
remodelling are given at the bottom of graph).
1.1.8(c) Gender.
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1.1.8(d) Culture and race.
fig. 1.7), 
Level of fracture
years
Fig.1.7. Cultural / racial differences in bone mass.fReid IR, 1997).
1.1. 8(e) Sex hormones.
1.1.8(f) Parathyroid hormone (PTH).
1.1.8(g) Calcitonin.
1.1.8(h) Insulin and insulin-like growth factors( somatomedins).
1.1.8(i) Growth hormone and Growth factors.
1.1.8(j) Thyroid hormone.
1.1.8(k) Prostaglandins (PCs).
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1.1.8(1) Cytokines.
appendix 4). 
1.1.9. Environmental factors, diet and life style.
1.1.9(a) Dietary calcium.
1.1.9(b) Dietary magnesium.
1.1.9(c) Dietary phosphates.
1.1.9(d) Dietary sodium and proteins.
1.1.9(e) Vegetarians / non-vegetarians.
1.1.9(f) Vitamin supplements.
1.1.9(g) Alcohol consumptions.
1.1.9(h) Caffeine consumptions.
1.1.9(i) Smoking.
1.1.9(j) Physical activities.

1.1.9(k) Reproductive history.
1.1.9(1) Diseases.
1.1.9(1) i Cushing's Syndrome.
1.1.9(1) ii Thyrotoxicosis.
1.1.9(1) iii Rheumatoid Arthritis.
1.1.9(1) iv Inflammatory bowels diseases.
1.1.9(1) v Hepatic disorders.
1.1.9(1) vi Diabetes Mellitus.
1.1.9(m) Drugs and hormone therapy.

1.1.10. BORON AND BONE TURNOVER.
1.1.10(a) Boron.
1.1.10(b) Chemistry of boron (B).
1.1.10(c) Physiological roles of boron.
Appendix 
1.1.10(d) Boron and ageing.
1.1.10(e) Boron and bone turnover.

1.1.11. Cortisol and bone.
l.l.ll(a) Biosynthesis, metabolism and excretion of cortisol.
1.1.1 l(b). Cortisol and bone turnover.
(fig. 1.8). 
13 3O 45 60 9O 2 3 4 5 ft a tO(Z IS 2O35 JO
*- *
Fig. 1.8. Cortisol production during fracture of the tibia and fibula
(stressor) (Guvton A. 1997).
1.1.12. Catecholamines and bone.
1.1.12(a) Biosynthesis, metabolism and excretion of catecholamines.
appendix 3). 
(fig. 1.9), 
Fig. 1.9. The metabolism of catecholamines. (Hall R. & Besser M. 1989X
fig.1.10).
\\ 
Fig.1.10. The biosynthesis of serotonin (Hall R & Besser M. 1989.
1.1.12 b. Catecholamines and bone turnover.

1.1.13. OSTEQPOROSIS.
(Fig. 
1.11).
1.1.13(a) Primary Osteoporosis.
Juvenile Osteoporosis.
Fig. 1.11. shows the increased rate of three common fractures in men and
women plotted against age. 
(Source: National Osteoporotic Society, 1994/1995).
Young adults and pre-menopausal Osteoporosis.
Post-menopausal Osteoporosis (Type 1).
Senile Osteoporosis (Type 2).
1.1.13(b) Secondary Osteoporosis ( Disease-induced).
(table 1.1).
1.1.13(c) Osteoporosis and bone changes.
(Fig. 1.12a & b).
Table 1.1. Aetiology of osteoporosis.
Genetic
Lifestyles
Dietary disorders
hormone deficiency
Endocrine disorders
Bone and bone marrow diseases
Kidney or liver diseases
Drugs
Figs. 1.12(a) Cortical bone: bone tissues lost from inside of bone and small 
amount of bone tissue added externally to adjust in old age (Birdwood G,
1996). 
( 1. tissue loss from inside bone 2. tissue added on external surface ).
(Figs. 1.13(a&b) & 
1.14(a&b). 
Fig. 1.12(b) Trabecular bone: bone tissues lost and become thinner;
thickening in old bones to compensate for lost tissues. 
( 1. as the tranverse trabeculae become progressively thin and disrupted, 2.
thickening of some vertical trabeculae compensate for the loss).
Fig. 1.13(a) Normal trabecular bone elements.
Fig. 1.13(b). Osteoporotic trabecular bone tissues showing loss of
trabecular elements.
(Source: 1.13(a&b):An atlas of osteoporosis by J.C. Stevenson & M.S.
Marsh, 1992).
Fig. 1.14(a). Normal cortical bone elements.
Fig. 1.14(b). Osteoporotic cortical bone tissues. 
(Source: 1.14 a&b, Parsons V, 1980 ).

1.1.14. Costs of dealing with osteoporosis and related fractures.

1.1.15. Aims of Project.

MATERIALS AND METHODS.
2.0.0. Introduction.
2.1.0. Rationale for selecting this subject.
2.2.0. Questionnaire (appendix 1).
2.3.0. Urine.
2.4.0. Access and ethical approval.
2.5.0. Urine analysis.
2.5.0(a) Calcium and Magnesium.
Preparation of reagents and standards.
Procedure.
Calcium: 
figure 2.1.
Magnesium: 
Figure 
2.5.0(b) Phosphate.
Preparation of reagents and standards.
Procedure.
(fig. 
2.5.0(c) Boron.
Preparation of standards for boron.
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Procedure.
2.5.0(d) Hydroxyproline.
Preparation of reagents and Standards.
Procedure
Figure 
2.5.0(e) Deoxypyridinoline analysis.
Fig. 2.6. 
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2.5.0(f) Cortisol.
Preparation of standard cortisol.
figure 
20 40 60 80 100 120
Cortisol ng / ml.
140 160 180 200
Preparation of urine samples.
Preparation of the mobile phase.
Procedure.
FLOW DIAGRAM OF THE HPLC SYSTEM
Reservoir
Pump Injection
Column
detector Waste
Chart recorder.
Fig.2.7a shows a diagrammatic flow chart of the HPLC system
analysis.
2.5.0(g) Catecholamines.
Equipments.
Collection of urine samples for catecholamine analysis
Preparation of the urine sample.
Bio-Rex Cation-Exchange Resin.
(fig. 
Preparation of the mobile phase buffer.

Preparation of Catecholamines Stock Standards.
(Table 
Figures 2.9, 2.10, 2.11 2.12 
100 200 300 400 500 600
Noradrenaline ng / ml
700 800 900 1000
100 200 300 400 500 600 700 800 900 1000
Adrenaline ng / ml
500 1000 1500
Dopamine ng/ml.
2000 2500 3000
Table 2.1. The volumes of working standards of catecholamines
and serotonin used.
(All made up to a final volume of 10 ml).
RUN i 8 
UORKFILE ID; B 
UORKFILE NAME:
HEIGHT*
RT
4.89 
5.64 
6.69 
8.0S
HEIGHT TYPE 
118674 PV 
67913 W 
51711 W 
35751 VV 
52961 BB
TOTAL HGHT= 
MUL FACTOR=
327619
flR/HT 
1.688 
6.936 
1.281 
d.883
HEIGHT? 
36.291 
20.768 
15.813 
18.333
NA AD DHBA DA
Fig. 2.13. A typical chromatographic recording of urinary
NA, AD and DA.
Fig. 2. 14. shows a typical chromatographic recording of urinary
serotonin (5 HT).
2.5.0(h) Relationship between plasma and urinary catecholamines.
Table 
Table 2.2. shows c a tec ho la mines level in plasma and urine before (1)
and after (2) moderate exercise.
2.5.0(i) Creatinine.
Preparation of reagents and standards.
Procedure.
Figure 2.14 
2.6.0. Statistical analysis.
RESULTS 
3.0.0. Introduction.
Fig. 3.1) 
3.1.0. The effects of age, gender and pregnancy on urinary analytes.
3.1.0(a) Urinary calcium.
(fig. 
3.1.0(b). Urinary magnesiun.
3.1.0(c). Urinary phosphate.
3.1.0(d). Urinary boron.
(fig.3.3). 
3.1.0(e). Urinary hydroxyproiine.
(fig.3.4).
3.1.0(f). Urinary cortisol.
3.1.0(g). Urinary noradrenaline.
3.1.0(h). Urinary adrenaline.
(Fig. 3.6).
3.1.0(i). Urinary dopamine.
3.1.0(j). Urinary serotonin.
3.1.0.(k) Urinary creatinine.
(fig. 

3.2.0. Correlation between urinary boron, stress hormones, serotonin and 
bone markers.
3.2.0(a). Introduction.
3.2.0(b). Urinary boron and bone markers.
fig. 3.9), 
3.2.0(c). Urinary cortisol and bone markers.
fig.3.10 
3.2.0(d). Urinary noradrenaline and bone markers .
= 
sy
fig.3.11 = 
= = 
?= 
3.2.0(e). Urinary adrenaline and bone markers .
fig.3.12), = 
= 
3.2.0(f). Urinary do pa mine and bone markers.
= 
= = 
3.2.0(g). Urinary serotonin and bone markers.
fig. 
= 
3.2.0(h). Urinary boron and stress hormones.
fig.3.14) 

3.3.0. Relationship between urinary bone markers, boron and stress 
hormones to specific life-styles, nutrients, reproductive factors and bone 
diseases (osteoporosis and osteoarthritis).
3.3.0.(a). Urinary calcium and alcohol intake .
(fig. 
3.3.0(b). Urinary magnesium and alcohol intake.
(Fig. 3.16). 
3.3.0(c). Urinary phosphate and alcohol intake.
3.3.0(d) Urinary boron and alcohol intake.
3.3.0(e). Urinary hydroxyproline and alcohol intake.
3.3.0(f). Urinary cortisol and alcohol intake.
3.3.0(g). Urinary noradrenaline and alcohol intake.
3.3.0(h). Urinary adrenaline and alcohol intake.
3.3.0(i). Urinary dopamine and alcohol intake.
3.3.0(j). Urinary serotonin and alcohol intake.
3.4.0(a). Urinary calcium and stress levels.
3.4.0(b). Urinary magnesium and stress levels.
3.4.0(c). Urinary phosphate and stress levels.
3.4.0(d). Urinary boron and stress levels.
tm^ 
(fig.3.18).
3.4.0(e). Urinary hydroxyproline and stress levels.
fig. 3.19).
3.4.0(f). Urinary cortisol and stress levels.
3.4.0(g). Urinary noradrenaline and stress levels.
(fig.3.21).
3.4.0(h). Urinary adrenaline and stress levels.
(fig . 
3.22). 
3.4.0(1). Urinary dopamine and stress levels.
3.4.0(j). Urinary serotonin and stress levels.
(fig.3.23).
3.5.0(a). Urinary calcium and exercise.
6 
(fig.3.24.).
3.5.0(b). Urinary magnesium and exercise.
3.5.0(c). Urinary phosphate and exercise.
F<20 F20- 
40
F>40 M<20 M20- 
40
M>40
(Fig. 3.25). 
3.5.0(d). Urinary boron and exercise.
(fig.3.26).
3.5.0(e). Urinary hydroxyproline and exercise.
(fig. 
3.5.0(f). Urinary cortisol and exercise.
3.5.0(g). Urinary noradrenaline and exercise.
3.5.0(h). Urinary adrenaline and exercise .
(fig.3.28). 
3.5.0(1). Urinary do pa mine and exercise.
3.5.0(j). Urinary serotonin and exercise.
(Fig. 
3.29).
3.6.0.(a). Urinary analyte levels of vegetarian / non-vegetarian 
subjects.
table 3.1. 
(fig. 3.30) 
Table 3.1. shows the levels of urinary analytes in vegetarians / non- 
vegetarians.

3.7.0(b). Urinary magnesium and vitamins supplements.
3.7.0(c). Urinary phosphate and vitamins supplements.
3.7.0(d). Urinary boron and vitamins supplements.
3.7.0(e). Urinary hydroxyproline and vitamins supplements.
3.7.0(f). Urinary cortisol and vitamins supplements.
3.7.0(g). Urinary noradrenaline and vitamins supplements.
(fig. 
3.33).
3.7.0(h). Urinary adrenaline and vitamins supplements.
3.7.0(i). Urinary dopamine and vitamins supplements .
3.7.0(j). Urinary serotonin and vitamins supplements.
3.8.0(a). Urinary calcium and subjects with a family history of bone 
diseases (osteoporosis -O/P- and osteoarthritis -O/A).
(fig.3.36).
3.8.0(b). Urinary magnesium and subjects with a family history of 
hone diseases (osteoporosis and osteoarthritis).
3.8.0(c). Urinary phosphate and subjects with a family history of 
bone diseases (osteoporosis and osteoarthritis).
3.8.0(d). Urinary boron and subjects with a family history of bone 
diseases (osteoporosis and osteoarthritis).
F<20 F20- 
40
F>40 M<20 M20- 
40
M>40
3.8.0 (e). Urinary hydroxyproline and subjects with a family history 
of bone diseases (osteoporosis and osteoarthritis).
3.8.0(£). Urinary cortisol and subjects with a family history of bone 
diseases (osteoporosis and osteoarthritis).
3.8.0(g). Urinary noradrenaline and subjects with a family history of 
bone diseases (osteoporosis and osteoarthritis).
3.8.0(h). Urinary adrenaline and subjects with a family history of 
bone diseases (osteoporosis and osteoarthritis).
(fig.3.38).
3.8.0(i). Urinary dopamine and subjects with a family history of bone 
diseases (osteoporosis and osteoarthritis).
3.8.0(j). Urinary serotonin and subjects with a family history of bone 
diseases (osteoporosis and osteoarthritis).
(fig.3.39).
3.9.0(a). Urinary calcium and cigarettes / tobacco smoking.
(fig.3.40). 
3.9.0(b). Urinary magnesium and cigarettes / tobacco smoking.
3.9.0(c). Urinary phosphate and cigarettes / tobacco smoking.
3.9.0(d). Urinary boron and cigarettes / tobacco smoking.
fig. 3.41 
3.9.0(e). Urinary hydroxyproline and cigarettes / tobacco smoking.
3.9.0(f). Urinary cortisol and cigarettes / tobacco smoking.
3.9.0(g). Urinary noradrenaline and cigarettes / tobacco smoking.
3.9.0(h). Urinary adrenaline and cigarettes / tobacco smoking.
(fig.3.42). 
3.9.0(i). Urinary dopamine and cigarettes / tobacco smoking.
3.9.0(j). Urinary serotonin and cigarettes / tobacco smoking.
3.10.0(a). Urinary calcium levels for subjects with bone diseases 
(osteoporosis and osteoarthritis).
table 3.2. 
Table 3.2. Shows urinary analytes levels in F>40 and M>40 with / 
without bone diseases (osteoporosis -O/P- & osteoarthritis- O/A).
(All values in fig/mg except calcium,magenesium & phosphate in mg/mg creatinine).
3.11.0(a). Urinary analytes levels for women with / without children 
and with multiple / first pregnancy.
table 3.3. 
Table 3.3. Shows levels of urinary analytes for women with and 
without children and pregnant women with children and pregnant
for the first time.
W>m^l^S^WSM^MS
3.12.0. Urinary analvtes levels for F20-40 pill / non-pill users.
table 3.4. 
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